Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Immunologic defects in 22q11.2 deletion syndrome.

McLean-Tooke A, Barge D, Spickett GP, Gennery AR.

J Allergy Clin Immunol. 2008 Aug;122(2):362-7, 367.e1-4. doi: 10.1016/j.jaci.2008.03.033. Epub 2008 May 16.

PMID:
18485468
2.

Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE.

Pediatrics. 2003 Oct;112(4):e325.

PMID:
14523220
3.

T-cell homeostasis in humans with thymic hypoplasia due to chromosome 22q11.2 deletion syndrome.

Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE.

Blood. 2004 Feb 1;103(3):1020-5. Epub 2003 Oct 2.

4.

Persistent low thymic activity and non-cardiac mortality in children with chromosome 22q11.2 microdeletion and partial DiGeorge syndrome.

Eberle P, Berger C, Junge S, Dougoud S, Büchel EV, Riegel M, Schinzel A, Seger R, Güngör T.

Clin Exp Immunol. 2009 Feb;155(2):189-98. doi: 10.1111/j.1365-2249.2008.03809.x. Epub 2008 Nov 24.

5.

Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Jawad AF, McDonald-Mcginn DM, Zackai E, Sullivan KE.

J Pediatr. 2001 Nov;139(5):715-23.

PMID:
11713452
6.

Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome.

McLean-Tooke A, Spickett GP, Gennery AR.

Scand J Immunol. 2007 Jul;66(1):1-7. Review.

7.

Maturational alterations of peripheral T cell subsets and cytokine gene expression in 22q11.2 deletion syndrome.

Kanaya Y, Ohga S, Ikeda K, Furuno K, Ohno T, Takada H, Kinukawa N, Hara T.

Clin Exp Immunol. 2006 Apr;144(1):85-93.

8.

Low thymic output in the 22q11.2 deletion syndrome measured by CCR9+CD45RA+ T cell counts and T cell receptor rearrangement excision circles.

Lima K, Abrahamsen TG, Foelling I, Natvig S, Ryder LP, Olaussen RW.

Clin Exp Immunol. 2010 Jul 1;161(1):98-107. doi: 10.1111/j.1365-2249.2010.04152.x. Epub 2010 May 10.

9.

Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome).

Finocchi A, Di Cesare S, Romiti ML, Capponi C, Rossi P, Carsetti R, Cancrini C.

Pediatr Allergy Immunol. 2006 Aug;17(5):382-8.

PMID:
16846458
10.

Lack of correlation between impaired T cell production, immunodeficiency, and other phenotypic features in chromosome 22q11.2 deletion syndromes.

Sullivan KE, Jawad AF, Randall P, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH.

Clin Immunol Immunopathol. 1998 Feb;86(2):141-6.

PMID:
9473376
11.

DiGeorge syndrome/chromosome 22q11.2 deletion syndrome.

Sullivan KE.

Curr Allergy Asthma Rep. 2001 Sep;1(5):438-44. Review.

PMID:
11892070
12.

Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome.

Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ.

Arch Dis Child. 2002 Jun;86(6):422-5.

13.

Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome.

Herwadkar A, Gennery AR, Moran AS, Haeney MR, Arkwright PD.

J Clin Pathol. 2010 Feb;63(2):151-5. doi: 10.1136/jcp.2009.072074.

PMID:
20154038
14.

Humoral immunity in DiGeorge syndrome.

Junker AK, Driscoll DA.

J Pediatr. 1995 Aug;127(2):231-7.

PMID:
7636647
15.

Low thymic output, peripheral homeostasis deregulation, and hastened regulatory T cells differentiation in children with 22q11.2 deletion syndrome.

Ferrando-Martínez S, Lorente R, Gurbindo D, De José MI, Leal M, Muñoz-Fernández MA, Correa-Rocha R.

J Pediatr. 2014 Apr;164(4):882-9. doi: 10.1016/j.jpeds.2013.12.013. Epub 2014 Jan 23.

PMID:
24461789
16.

Selective IgM deficiency and 22q11.2 deletion syndrome.

Kung SJ, Gripp KW, Stephan MJ, Fairchok MP, McGeady SJ.

Ann Allergy Asthma Immunol. 2007 Jul;99(1):87-92.

PMID:
17650836
17.

Immunological aspects of 22q11.2 deletion syndrome.

Gennery AR.

Cell Mol Life Sci. 2012 Jan;69(1):17-27. doi: 10.1007/s00018-011-0842-z. Epub 2011 Oct 9. Review.

PMID:
21984609
18.

Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).

Pierdominici M, Mazzetta F, Caprini E, Marziali M, Digilio MC, Marino B, Aiuti A, Amati F, Russo G, Novelli G, Pandolfi F, Luzi G, Giovannetti A.

Clin Exp Immunol. 2003 May;132(2):323-31.

19.

Early development of immunity in diGeorge syndrome.

Sedivá A, Bartůnková J, Zachová R, Poloucková A, Hrusák O, Janda A, Kocárek E, Novotná D, Novotná K, Klein T.

Med Sci Monit. 2005 Apr;11(4):CR182-7. Epub 2005 Mar 24.

PMID:
15795698
20.

The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome.

Sullivan KE.

Curr Opin Allergy Clin Immunol. 2004 Dec;4(6):505-12. Review.

PMID:
15640691

Supplemental Content

Support Center